Jennifer Smart
Family Medicine · Easley, SCNPI 1871770891
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 503 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,300 and has fallen 91.7% since, to $191 in 2025. Among family medicine clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 503 payments — averaging $13.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AstraZeneca$689
- Lilly USA, LLC$652
- Amgen$557
- GSK$494
- AbbVie$371
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,64597%
- Education$1963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 90 | $1,086 |
| AstraZeneca | 41 | $689 |
| Lilly USA, LLC | 58 | $652 |
| Amgen | 34 | $557 |
| GSK | 34 | $494 |
| AbbVie(2 entities) | 39 | $371 |
| Boehringer Ingelheim | 27 | $369 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $313 |
| Astellas Pharma US Inc | 13 | $305 |
| Merck | 25 | $229 |
| Johnson & Johnson | 18 | $204 |
| Sanofi-aventis U.S. LLC | 12 | $198 |
| Biohaven Pharmaceuticals, Inc. | 15 | $177 |
| Pfizer | 10 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| Amarin Pharma, Inc. | 6 | $113 |
| Dexcom, Inc. | 5 | $103 |
| Esperion Therapeutics, Inc. | 7 | $102 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Arbor Pharmaceuticals, Inc. | 5 | $69 |
| Abbott | 4 | $55 |
| Eisai Inc. | 4 | $55 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Novartis | 3 | $42 |
| Boston Scientific | 3 | $42 |
| Bayer | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Philips North America LLC | 2 | $26 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Exact Sciences | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $11 |
How this compares
$6,840 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 27 | $29,091 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $23,930 |
| OzempicSemaglutide | 25 | $23,749 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $15,503 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $3,865 |
| Levothyroxine Sodium | 108 | $901 |
| Losartan Potassium | 80 | $737 |
| Amlodipine Besylate | 140 | $669 |
| Rosuvastatin Calcium | 90 | $648 |
| Olmesartan Medoxomil | 18 | $605 |
| Omeprazole | 52 | $456 |
| Gabapentin | 17 | $445 |
| Metformin Hcl ErMetformin Hcl | 33 | $385 |
| Escitalopram Oxalate | 28 | $375 |
| Atorvastatin Calcium | 78 | $346 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $652 | $29,09127 claims |
| Novo NordiskOzempic | $1,086 | $23,74925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Easley
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.